trending Market Intelligence /marketintelligence/en/news-insights/trending/76MO6n60y6hxPn2TduE6aA2 content esgSubNav
In This List

PTC Therapeutics appoints 2 directors

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

PTC Therapeutics appoints 2 directors

PTC Therapeutics Inc. appointed Emma Reeve and Stephanie Okey to its board.

Reeve is the CFO of Constellation Pharmaceuticals Inc., while Okey was recently the senior vice president, head of North America at Genzyme's rare disease unit.

PTC Therapeutics is a biopharmaceutical company focused on developing medicines to treat rare disorders.